{"id":"https://openalex.org/W2937561995","doi":"https://doi.org/10.1093/schbul/sbz019.386","title":"T106. KARXT: A M1/M4 PREFERRING MUSCARINIC AGONIST FOR THE TREATMENT OF SCHIZOPHRENIA","display_name":"T106. KARXT: A M1/M4 PREFERRING MUSCARINIC AGONIST FOR THE TREATMENT OF SCHIZOPHRENIA","publication_year":2019,"publication_date":"2019-04-01","ids":{"openalex":"https://openalex.org/W2937561995","doi":"https://doi.org/10.1093/schbul/sbz019.386","mag":"2937561995"},"language":"en","primary_location":{"id":"doi:10.1093/schbul/sbz019.386","doi":"https://doi.org/10.1093/schbul/sbz019.386","is_oa":false,"landing_page_url":"https://doi.org/10.1093/schbul/sbz019.386","pdf_url":null,"source":{"id":"https://openalex.org/S117485531","display_name":"Schizophrenia Bulletin","issn_l":"0586-7614","issn":["0586-7614","1745-1701","1745-1707"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Schizophrenia Bulletin","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6455874","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019090648","display_name":"Stephen K. Brannan","orcid":"https://orcid.org/0000-0003-0922-5970","observed_orcids":["https://orcid.org/0000-0003-0922-5970"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Brannan","raw_affiliation_strings":["Karuna Pharmaceuticals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karuna Pharmaceuticals","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103198015","display_name":"Andrew Miller","orcid":"https://orcid.org/0000-0002-4330-320X","observed_orcids":["https://orcid.org/0000-0002-4330-320X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Miller","raw_affiliation_strings":["Karuna Pharmaceuticals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karuna Pharmaceuticals","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013032842","display_name":"Christian C. Felder","orcid":"https://orcid.org/0000-0003-1134-8881","observed_orcids":["https://orcid.org/0000-0003-1134-8881"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christian Felder","raw_affiliation_strings":["Karuna Pharmaceuticals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karuna Pharmaceuticals","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101815684","display_name":"Steven M. Paul","orcid":"https://orcid.org/0009-0009-2773-8025","observed_orcids":["https://orcid.org/0009-0009-2773-8025","https://orcid.org/0000-0002-8388-2023"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Paul","raw_affiliation_strings":["Karuna Pharmaceuticals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karuna Pharmaceuticals","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110607987","display_name":"Alan F. Breier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Breier","raw_affiliation_strings":["Indiana University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University School of Medicine","institution_ids":["https://openalex.org/I4394709130"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4981,"currency":"USD","value_usd":4981},"apc_paid":null,"fwci":0.199,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.55436612,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"45","issue":"Supplement_2","first_page":"S244","last_page":"S245"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/xanomeline","display_name":"xanomeline","score":0.9760000109672546},{"id":"https://openalex.org/keywords/trospium","display_name":"trospium","score":0.984000027179718}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7479188442230225},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.598236083984375},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5753382444381714},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.5533725619316101},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5497251152992249},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.4783617854118347},{"id":"https://openalex.org/C2779600325","wikidata":"https://www.wikidata.org/wiki/Q6940221","display_name":"Muscarinic agonist","level":4,"score":0.47821924090385437},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4614146947860718},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.45639604330062866},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44132545590400696},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4199378490447998},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3487985134124756},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05599212646484375},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/schbul/sbz019.386","doi":"https://doi.org/10.1093/schbul/sbz019.386","is_oa":false,"landing_page_url":"https://doi.org/10.1093/schbul/sbz019.386","pdf_url":null,"source":{"id":"https://openalex.org/S117485531","display_name":"Schizophrenia Bulletin","issn_l":"0586-7614","issn":["0586-7614","1745-1701","1745-1707"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Schizophrenia Bulletin","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:6058698","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6455874","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6455874","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6455874","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Schizophr Bull","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:6058698","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6455874","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.44999998807907104,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3023112558","https://openalex.org/W4362735013","https://openalex.org/W7141169460","https://openalex.org/W4406254531","https://openalex.org/W7128537149","https://openalex.org/W4310777355","https://openalex.org/W4280647978","https://openalex.org/W7155085307","https://openalex.org/W4392379200","https://openalex.org/W4406254496"],"abstract_inverted_index":{"Xanomeline":[0],"is":[1,437,522,548],"a":[2,58,89,106,147,155,168,523],"M1":[3],"/M4":[4],"preferring":[5],"muscarinic":[6],"agonist":[7],"that":[8,53,63,306,397,520],"has":[9],"demonstrated":[10,52],"antipsychotic":[11,489],"and":[12,22,38,136,139,183,209,223,247,339,346,367,405,409,429,436,455,507,518],"pro-cognitive":[13],"effects":[14,130,270],"in":[15,114,186,203,275,291,308,348,357,363,379,392,433,441,473,501],"both":[16],"schizophrenia":[17],"(Shekar,":[18],"et":[19,26],"al,":[20,27],"2008)":[21],"Alzheimer\u2019s":[23],"disease":[24],"(Bodick":[25],"1997).":[28],"However,":[29],"its":[30,42,75],"peripheral":[31,59,79,127],"cholinergic":[32,60,80,128,233],"side":[33,81,129],"effects,":[34],"including":[35],"nausea,":[36],"vomiting":[37],"diarrhea,":[39,133],"have":[40],"prevented":[41],"continued":[43],"clinical":[44,50],"development.":[45],"A":[46],"previous":[47,311,545],"Phase":[48,90],"I":[49],"trial":[51],"the":[54,67,86,98,115,231,250,276,320,328,352,416,453,462,470,502],"addition":[55],"of":[56,88,100,123,146,151,158,198,207,212,227,252,268,282,287,295,324,333,351,427,457,465,482,509],"trospium,":[57,228],"receptor":[61],"antagonist":[62],"does":[64],"not":[65,479],"cross":[66],"blood":[68],"brain":[69],"barrier,":[70],"to":[71,249,305,370,399,413,513,536],"xanomeline":[72,101,161,178,213,240,294,388,406,428,553],"substantially":[73,549],"improved":[74],"tolerability":[76,456,471,527],"by":[77,167],"reducing":[78],"effects.":[82],"We":[83],"now":[84],"report":[85],"results":[87],"1,":[91],"multi-dose":[92],"safety":[93,138,454,497],"study":[94,122,142,314,329,477],"aimed":[95],"at":[96,336],"optimizing":[97],"combination":[99,187],"with":[102,188,220,239,384,387,443,543],"trospium":[103,165,189,243,264,404],"(KarXT)":[104],"using":[105,420],"new":[107,424,496],"BID":[108,211,226,265,281],"co-formulation.":[109],"69":[110],"healthy":[111,434,475,493],"volunteers":[112],"participated":[113],"phase":[116,312],"1":[117,313],"multiple":[118],"ascending":[119],"dose":[120,157,244],"(MAD)":[121],"KarXT":[124,156,368,375,425,547],"focusing":[125],"on":[126,261,293],"(nausea,":[131],"vomiting,":[132],"excess":[134],"sweating":[135],"salivation),":[137],"tolerability.":[140],"The":[141,172,195,284,331,423,505],"design":[143],"was":[144,200,303],"comprised":[145],"2-day":[148,196],"titration":[149,197],"period":[150],"either":[152],"placebo":[153,366],"or":[154,192,299,326,360],"50":[159],"mg":[160,164,182,185,191,222,225,263,280,297,301,338,341],"+":[162],"20":[163,190,221],"followed":[166],"5-day":[169],"treatment":[170],"period.":[171],"doses":[173],"(all":[174],"BID)":[175],"assessed":[176],"were:":[177],"100":[179,208,296,337],"mg,":[180],"125":[181,210,279,300,340],"150":[184],"40":[193,224,262],"mg.":[194],"50/20":[199],"well":[201,216,432,460],"tolerated":[202,217,551],"all":[204,532],"cohorts.":[205],"Doses":[206],"were":[214,237,344,395,411,418,499,511],"also":[215],"when":[218],"paired":[219],"respectively.":[229],"Across":[230],"cohorts,":[232],"adverse":[234,255],"events":[235,256],"(ChAEs)":[236],"correlated":[238],"dose.":[241],"Increasing":[242],"ameliorated":[245],"ChAEs,":[246],"lead":[248],"observance":[251],"some":[253],"anticholinergic":[254,269],"(AEs).":[257],"Some":[258],"cohorts":[259,292,353,373],"tested":[260,440],"reported":[266,500],"signs":[267],"(i.e.,":[271],"dry":[272],"mouth),":[273],"particularly":[274],"cohort":[277],"receiving":[278,374],"xanomeline.":[283],"total":[285],"number":[286],"subjects":[288,435],"reporting":[289],"ChAEs":[290,317],"(39%)":[298],"(33%)":[302],"similar":[304],"seen":[307],"KAR-001,":[309],"our":[310,544],"(34%).":[315],"Most":[316],"occurred":[318],"within":[319],"first":[321],"few":[322],"days":[323],"starting":[325],"increasing":[327],"drug.":[330],"majority":[332],"these":[334],"AEs":[335,466,510,533],"xanomeline-dose":[342],"levels":[343,516,538],"mild":[345],"transient":[347],"nature.":[349],"None":[350],"showed":[354,376],"meaningful":[355],"changes":[356],"orthostatic":[358],"HR":[359,382,394],"obvious":[361],"differences":[362],"BP":[364],"between":[365],"compared":[369],"placebo.":[371],"All":[372],"placebo-adjusted":[377],"increases":[378,391],"mean":[380],"resting":[381,393],"consistent":[383],"past":[385],"studies":[386,447],"where":[389,415],"short-term":[390],"observed":[396,472],"normalized":[398],"baseline":[400,537],"over":[401,467,528],"time.":[402,468,529],"Both":[403],"exposures":[407],"(AUCs)":[408],"variability":[410],"comparable":[412],"KAR-001":[414],"compounds":[417],"given":[419],"separate":[421],"formulations.":[422],"co-formulation":[426],"tropsium":[430],"performed":[431],"currently":[438,487],"being":[439],"patients":[442],"schizophrenia.":[444],"Longer":[445],"terms":[446],"will":[448],"provide":[449],"further":[450],"data":[451],"around":[452],"KarXT,":[458],"as":[459,461],"possible":[463],"attenuation":[464],"Importantly,":[469],"this":[474],"volunteer":[476],"may":[478],"be":[480],"representative":[481],"schizophrenic":[483],"patients,":[484],"who":[485],"tolerate":[486],"marketed":[488],"medicine":[490],"better":[491,550],"than":[492,552],"volunteers.":[494],"No":[495],"signals":[498],"present":[503],"study.":[504],"timing":[506],"duration":[508],"related":[512],"peak":[514],"drug":[515],"(Cmax)":[517],"suggest":[519],"there":[521],"potential":[524],"for":[525],"increased":[526],"In":[530],"addition,":[531],"rapidly":[534],"returned":[535],"upon":[539],"dosing":[540],"discontinuation.":[541],"Consistent":[542],"studies,":[546],"alone.":[554]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2019-04-25T00:00:00"}